Instrument Inactif

Cours Ambit Biosciences Corp

Actions

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

Ambit Biosciences : Daiichi Sankyo and Ambit Announce Results of Tender Offer	11/11/14
Ambit Biosciences : Announces Expiration of Hart-Scott-Rodino Waiting Period	28/10/14
Ambit Biosciences : Announcement Regarding Submission of Tender Offer for Shares in Ambit Biosciences Corporation	14/10/14
Ambit Biosciences : Stockholders Encouraged to Contact Securities Law Firm about Takeover	01/10/14
Ambit Biosciences : Ryan & Maniskas, LLP : Announces Investigation of Ambit Biosciences Corporation	01/10/14

Dirigeants	Titre	Age	Depuis
Ken Takeshita CEO	Chief Executive Officer	-	-

Administrateurs	Titre	Age	Depuis
Kenneth Joseph Keller BRD	Director/Board Member	61	10/11/14
Michael Martino CEO	Chief Executive Officer	68	16/11/11
Glenn Gormley BRD	Director/Board Member	-	10/11/14

Secteur

	Varia. 1 janv.	Capi.
CSL LIMITED	-3,45%	87,17 Md
SAMSUNG BIOLOGICS CO.,LTD.	+2,76%	40,1 Md
BIOGEN INC.	-16,98%	31,38 Md
UCB	+57,86%	25,12 Md
BIOMARIN PHARMACEUTICAL INC.	-16,24%	15,59 Md
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9,12%	12 Md
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-42,56%	11,8 Md
INCYTE CORPORATION	-17,10%	11,8 Md
SWEDISH ORPHAN BIOVITRUM AB	+6,89%	8,81 Md